National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

Found 16,766 cases where Vaccine targets COVID-19 (COVID19) and Patient Died



Case Details

This is page 1280 out of 1,677

Result pages: prev   1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289   next


VAERS ID: 1428702 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-05-04
Onset:2021-05-01
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Fall, Femur fracture, General physical health deterioration, Investigation
SMQs:, Accidents and injuries (narrow), Osteoporosis/osteopenia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-13
   Days after onset: 12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atherosclerosis; Heart failure NYHA class IV; Pertrochanteric fracture of femur, closed; Pneumonia bacterial
Allergies:
Diagnostic Lab Data: Test Date: 202105; Test Name: Examinations; Result Unstructured Data: Test Result:pertrochanteric fracture
CDC Split Type: HUPFIZER INC2021689192

Write-up: Death/poor general condition; fall; fall; This is a spontaneous report from a contactable physician downloaded from a regulatory authority HU-OGYI-394021 This spontaneous, serious, medically confirmed case was reported on 27May2021 by a physician and concerns the occurrence of death after COMIRNATY injection for active immunization to prevent COVID-19. On 04May2021 the 87-years-old female patient received the second dose of 0.3 ml BNT162B2 (COMIRNATY) concentrate for dispersion for injection (tozinameran (COVID-19 mRNA Vaccine embedded in lipid nanoparticles), batch number: unknown, expiry date: unknown, MAH: BioNTech Manufacturing GmbH/Pfizer) to prevent Covid-19. Medical history included NYHA class IV heart failure, bacterial pneumonia and atherosclerosis, pertrochanteric fracture of femur, closed. Concomitant drugs were not reported. The patient was hospitalized on 09May2021 after a fall. Examinations showed a pertrochanteric fracture which required surgery, but as the patient general condition was bad, she was unfit to have the surgery. Despite treatment, the patient passed away on 13May2021 at 06:10. Autopsy was performed. Further information is not expected. Sender Comment: As the patient was hospitalized because of a fall and then passed away due to her poor general condition, the causal relationship is unlikely between the suspected drug and the adverse event. The case is considered serious because the outcome was fatal. Further information is not expected. No follow-up attempts are possible, information on batch/lot number cannot be obtained.; Reported Cause(s) of Death: poor general condition


VAERS ID: 1428703 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-05-05
Onset:2021-05-01
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Fall, Femur fracture, General physical health deterioration, Laboratory test, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Accidents and injuries (narrow), Osteoporosis/osteopenia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-16
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atherosclerosis; COPD; Ischemic heart disease; Pneumonia hypostatic
Allergies:
Diagnostic Lab Data: Test Date: 202105; Test Name: Examinations; Result Unstructured Data: Test Result:a pertrochanteric fracture on the left side
CDC Split Type: HUPFIZER INC2021689193

Write-up: condition deteriorated; fall; pertrochanteric fracture on the left side; Death/ heart attack contributed to her death; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB HU-OGYI-394121. An 83-year-old female patient received second dose of bnt162b2 (COMIRNATY, Batch/Lot Number: Unknown), intramuscularly on 05May2021 as 0.3 ml single dose for covid-19 immunisation. Medical history included ischemic heart disease, atherosclerosis, chronic obstructive pulmonary disease (COPD) and hypostatic pneumonia. Concomitant drugs were not reported. The patient previously received first dose of bnt162b2 (Batch/Lot Number: Unknown) on unknown date as single dose for covid-19 immunisation. The patient was hospitalized on 14May2021 after a fall. Examinations showed a pertrochanteric fracture on the left side. The patient received surgery, but despite therapy, her condition deteriorated. The patient passed away on 16May2021 at 16:10. The outcome of events fall and pertrochanteric fracture was unknown. The patient died on 16May2021. An autopsy was performed but results were not provided. Sender Comment: As the patient was hospitalized because of a fall and then passed away due to her general condition in association with her primary diseases, the causal relationship is unlikely between the suspected drug and the adverse event. The patient also had a recent heart attack which also contributed to her death. The case is considered serious because the outcome was fatal. Further information is not expected. No follow-up Information on batch/lot number cannot be obtained attempts are possible. No further information expected.; Sender''s Comments: Based on the information provided by the reporter, it appears unlikely that subject vaccine contributed to the myocardial infarction and the other events. The reported events likely represent intercurrent medical conditions. There is limited information provided in this report. This case will be reassessed upon receipt of follow-up information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: heart attack contributed to her death; condition deteriorated


VAERS ID: 1428704 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-26
Onset:2021-05-01
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET6956 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, COVID-19 pneumonia, SARS-CoV-2 test, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-16
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chronic lymphocytic leukaemia (cytostatic treatments); COVID-19; COVID-19 pneumonia; GERD; Hypertension
Allergies:
Diagnostic Lab Data: Test Date: 202105; Test Name: COVID-19 antigen test; Test Result: Positive
CDC Split Type: HUPFIZER INC2021730992

Write-up: COVID-19; Vaccination failure; COVID-19 pneumonia; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB. Regulatory authority number HU-OGYI-415121. A 79-years-old female patient received bnt162b2 (COMIRNATY, solution for injection, Lot Number: ET6956), via intramuscular route in the left arm on 26Apr2021 as DOSE 2, 0.3 ML, single dose for covid-19 immunization and first dose of bnt162b2 (COMIRNATY, solution for injection, Lot Number: EZ3620), via on an unspecified route of administration on 22Mar2021 as DOSE 1, single for covid-19 immunization. The patient''s medical history included hypertension, covid-19 pneumonia, chronic lymphocytic leukaemia in Feb2003 and received cytostatic treatments, covid-19 and gastrooesophageal reflux disease. The patient''s concomitant medications were not reported. The patient was hospitalized on 04May2021 after experiencing Covid-19 symptoms. Antigen test was positive. The patient received covid therapy, but her respiratory insufficiency progressed and was transferred to the Intensive Care Unit on 09May2021. Despite therapy, permanent improvement of the patients condition could not be reached. The patient passed away on 16May2021 at 18:49 due to Covid-19 pneumonia and ARDS. Sender Comment: The patient got infected with Covid-19 approximately 1 week after the second dose, therefore vaccination failure is considered possible. The case is serious because the outcome was fatal. Further information is not expected. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: ARDS; COVID-19


VAERS ID: 1428705 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-01
Onset:2021-05-08
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3001939 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Blood pressure measurement, Heart rate, Heart rate increased, Hemiparesis, Hypertension, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (broad), Hypertension (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-21
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension; Joint pain
Allergies:
Diagnostic Lab Data: Test Date: 20210508; Test Name: Blood pressure; Result Unstructured Data: Increased; Test Date: 20210508; Test Name: Pulse rate; Result Unstructured Data: Rapid pulse
CDC Split Type: HUMODERNATX, INC.MOD20212

Write-up: (209/120 Hgmm); (115/min); This regulatory authority case was reported by a physician and describes the occurrence of HEMIPARESIS (hemiparesis), HYPERTENSION (209/120 Hgmm), HEART RATE INCREASED (115/min) and VACCINATION FAILURE in a 66-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3001939) for COVID-19 vaccination. The patient''s past medical history included Hypertension and Joint pain. On 01-May-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) .5 milliliter. On 08-May-2021, the patient experienced HEMIPARESIS (hemiparesis) (seriousness criteria death, hospitalization and medically significant), HYPERTENSION (209/120 Hgmm) (seriousness criteria death and hospitalization) and HEART RATE INCREASED (115/min) (seriousness criteria death and hospitalization). On 21-May-2021, the patient experienced VACCINATION FAILURE (seriousness criteria death and hospitalization). The patient died on 21-May-2021. The cause of death was not reported. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-May-2021, Blood pressure measurement: 209/120 mmhg (High) Increased. On 08-May-2021, Heart rate: 115 (High) Rapid pulse. mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosing remained unchanged. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported. No treatment details provided. This fatal case concerns a 66-year-old male with serious unexpected events of hemiparesis, hypertension, heart rate increased, and vaccination failure. Event latency 8 days after first dose mRNA-1273. Outcome death. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender''s Comments: This fatal case concerns a 66-year-old male with serious unexpected events of hemiparesis, hypertension, heart rate increased, and vaccination failure. Event latency 8 days after first dose mRNA-1273. Outcome death. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1428709 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-11
Onset:2021-05-11
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Aortic aneurysm rupture, Dyspnoea, Loss of consciousness, SARS-CoV-2 RNA
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-11
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal aortic aneurysm; Hypertension; Ischaemic heart disease; Peripheral vascular disease; Triple vessel bypass graft (triple bypass 18 years ago)
Allergies:
Diagnostic Lab Data: Test Date: 20210513; Test Name: SARS-CoV-2 RNA; Test Result: Negative
CDC Split Type: IEPFIZER INC2021688266

Write-up: BREATHLESSNESS; RUPTURED ATHEROSCLERSIS ABDOMINAL AORTIC ANEURYSM; COLLAPSE; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority-WEB, regulatory authority number IE-HPRA-2021-073777. A 75-years-old male patient received BNT162B2 (COMIRNATY), second dose via intramuscular, administered in right upper deltoid on 11May2021 15:25 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation (at the age of 75 years old). The patient''s medical history/concurrent conditions included hypertension, peripheral vascular disease, abdominal aortic aneurysm (aortic aneurysm), triple vessel bypass graft in 2003, triple bypass 18 years ago (coronary artery bypass), and ischaemic heart disease (myocardial ischaemia). The patient''s concomitant medications were not reported. Historical vaccine included first dose on unspecified dose for covid-19 immunisation. The patient experienced collapse on 11May2021, breathlessness 11May2021 18:25, ruptured atherosclersis abdominal aortic aneurysm on 11May2021. Initial report was received by the HPRA on 12May2021 from a Coroner. This report concerned a 75 years old male who experienced dyspnoea, loss of consciousness and died following vaccination with Comirnaty for COVID-19 immunisation. No information was provided regarding the patient''s concomitant medication. 3 hours post vaccination, the patient experienced breathlessness followed by collapse. Follow-up information was received by the HPRA from a Coroner on 14May2021: On 11May2021, the patient complained of shortness of breath at 18:25. It was noted the patient died within a 3 hour following administration of second dose of Comirnaty. On 13May2021, the post-mortem report indicated that the cause of death was ruptured atherosclerosis abdominal aortic aneurysm. It was noted that nasopharyngeal swab was obtained, which SARS-CoV-2 RNA was not detected. The patient underwent lab tests and procedures which included SARS-CoV-2 RNA: negative on 13May2021. The outcome for events was fatal. At the time of reporting, a Coroner''s autopsy had been directed. An autopsy was performed that revealed ruptured atherosclerosis abdominal aortic aneurysm (aortic aneurysm rupture). No follow up attempts are possible; Information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Ruptured atherosclerosis abdominal aortic aneurysm; Autopsy-determined Cause(s) of Death: Ruptured atherosclerosis abdominal aortic aneurysm


VAERS ID: 1428710 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-05-13
Onset:2021-05-13
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Acute myocardial infarction, Malaise, SARS-CoV-2 RNA undetectable, Unresponsive to stimuli
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-16
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: WARFARIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Aortic valve replacement; Chronic ischaemic heart disease, unspecified
Allergies:
Diagnostic Lab Data: Test Date: 20210519; Test Name: SARS-CoV-2 RNA undetectable; Result Unstructured Data: Test Result:nasopharyngeal swab, not detected.
CDC Split Type: IEPFIZER INC2021688261

Write-up: RUPTURED ACUTE MYOCARDIAL INFARCTION OF THE ANTERIOR ASPECT OF THE LEFT VENTRICLE; unresponsive; FEELING UNWELL; This is a spontaneous report from a contactable other healthcare professional (Coroner) downloaded from the a regulatory authority. The regulatory authority report number is [IE-HPRA-2021-074281]. A 57-years-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 13May2021 (Lot Number: Unknown) as single dose for covid-19 immunization at the age of 57 years old. Medical history included Chronic ischaemic heart disease, unspecified and aortic valve replacement. Concomitant medication(s) included warfarin. The patient experienced feeling unwell on 13May2021, ruptured acute myocardial infarction of the anterior aspect of the left ventricle on 16May2021. Reported as: On 13May2021, following vaccination, the patient felt unwell that night, next day and again on 16May2021. On 16May2021, the patient was found unresponsive on the floor at home. Given the temporal relationship between the first vaccine and death, a Coroner''s autopsy was directed. On 19May2021, the post-mortem report indicated that the cause of death was a ruptured acute myocardial infarction of the anterior aspect of the left ventricle in the context of chronic ischaemic heart disease and aortic valve replacement. It was noted that nasopharyngeal swab was obtained, which SARS-CoV-2 RNA was not detected on 19May2021. The patient died on 16May2021. An autopsy was performed that revealed ruptured acute myocardial infarction of the anterior aspect of the left ventricle. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: unresponsive; RUPTURED ACUTE MYOCARDIAL INFARCTION OF THE ANTERIOR ASPECT OF THE LEFT VENTRICLE; FEELING UNWELL; Autopsy-determined Cause(s) of Death: RUPTURED ACUTE MYOCARDIAL INFARCTION OF THE ANTERIOR ASPECT OF THE LEFT VENTRICLE


VAERS ID: 1428758 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-10
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 2 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Atrial fibrillation, Cerebral ischaemia, Coma, Paresis
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Supraventricular tachyarrhythmias (narrow), Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-17
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthritis rheumatoid; Diabetes
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021687995

Write-up: paresis; Coma; cerebral ischaemia; atrial fibrillations; This is a spontaneous report received from a contactable consumer downloaded from a regulatory authority-WEB. The regulatory authority report number is IT-MINISAL02-740023. A 80 years old female patient received second dose BNT162B2 (COMIRNATY, lot number ET7205), intramuscular at Arm Right on 01APR2021 at single dose for SARS-CoV-2 vaccination. The medical history included Diabetes and Arthritis rheumatoid. The concomitant medications were not reported. At 9 days after second dose on 10APR2021, the patient experienced cerebral ischaemia, paresis, atrial fibrillations, coma and death after 7 days on 17APR2021. The patient died on 17APR2021. It''s unknown if an autopsy was performed. The cause of death was cerebral ischaemia, paresis, atrial fibrillations, coma. The outcome of the event was fatal. Reporter''s comments:Rheumatoid arthritis, diabetes No follow-up attempts possible. No further information expected.; Reporter''s Comments: Rheumatoid arthritis, diabetes; Reported Cause(s) of Death: paresis; Coma; cerebral ischaemia; atrial fibrillations


VAERS ID: 1428818 (history)  
Form: Version 2.0  
Age: 28.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-06-04
Onset:2021-06-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EX3617 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Body temperature increased, Cardiac failure acute
SMQs:, Cardiac failure (narrow), Neuroleptic malignant syndrome (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-06-08
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210604; Test Name: Body temperature; Result Unstructured Data: Test Result:36.7 Centigrade; Comments: before vaccination; Test Date: 20210604; Test Name: Body temperature; Result Unstructured Data: Test Result:37.5 Centigrade; Test Date: 20210605; Test Name: Body temperature; Result Unstructured Data: Test Result:39 Centigrade; Test Date: 20210606; Test Name: Body temperature; Result Unstructured Data: Test Result:38 Centigrade; Test Date: 20210607; Test Name: Body temperature; Result Unstructured Data: Test Result:36.1 Centigrade
CDC Split Type: JPPFIZER INC2021679058

Write-up: Acute cardiac insufficiency; body temperature was 37.5 degrees centigrade / body temperature was 39 degrees centigrade / body temperature was 38 degrees centigrade; This is a spontaneous report from a contactable physician received from a regulatory authority (RA). Regulatory authority report number is v21112718 and v21112921. The patient was a 28-year-old male. Body temperature before vaccination was 36.7 degrees centigrade. Family history was not reported. On 14May2021, the patient previously received the first dose of BNT162b2 (COMIRNATY, Lot# EX3617, Expiration date 31Aug2021). On 04Jun2021 (the day of vaccination), the patient received the second dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number EX3617, Expiration date 31Aug2021) via an unspecified route of administration as a single dose for COVID-19 immunization at age of 28-year-old. On 08Jun2021 (4 days after the vaccination), the patient experienced death. On 08Jun2021 (4 days after the vaccination), the outcome of the event was fatal. Event/cause of death was acute cardiac insufficiency. The course of the event was as follows: On 04Jun2021, on the day of the second vaccination, the patient''s body temperature was 37.5 degrees centigrade. On 05Jun2021, body temperature was 39 degrees centigrade. On 06Jun2021, body temperature was 38 degrees centigrade, for which the patient took a day off work. On 07Jun2021, body temperature was 36.1 degrees centigrade and the patient worked from 12:00 to 21:00. On 08Jun2021, the patient was scheduled to work but did not come to the workplace. A staff visited the patient''s home but could not get in; thus, the staff called a fire department and the patient was found to be dead in the room. Pathological autopsy was conducted at university. As a result of pathological autopsy, cause of death was identified as acute cardiac insufficiency. Outcome of the event body temperature increased was recovered on 07Jun2021. The reporting physician classified the event as serious (death) and assessed that the causality between the event and BNT162b2 as unassessable. Other possible cause of the event such as any other diseases was unknown. The reporting physician commented as follows: At the time of this report, causality was unknown.; Reported Cause(s) of Death: Acute cardiac insufficiency; Autopsy-determined Cause(s) of Death: Acute cardiac insufficiency


VAERS ID: 1428827 (history)  
Form: Version 2.0  
Age: 93.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-04
Onset:2021-06-07
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-06-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EY2173 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Cardio-respiratory arrest, Respiratory arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Hypersensitivity (broad), Respiratory failure (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-06-09
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Cerebral arterial aneurysm; Consciousness disturbance transient; Late effects of cerebral infarction; Old cerebral infarction; Subarachnoid haemorrhage
Allergies:
Diagnostic Lab Data: Test Date: 20210604; Test Name: body temperature; Result Unstructured Data: Test Result:37.1 Centigrade
CDC Split Type: JPPFIZER INC2021679397

Write-up: Cardio-respiratory arrest / Cardiac arrest; Respiratory arrest; This is a spontaneous report from a contactable physician (via a Pfizer sales representative) received from the Agency Regulatory Authority. Regulatory authority report number is v21113766. The patient was a non-pregnant 93-year-old female. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had received unspecified prescribed drugs within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Since the vaccination, the patient has not been tested for COVID-19. Other medical history included histories of atrial fibrillation, old cerebral infarction, cerebral arterial aneurysm, subarachnoid haemorrhage, and persistent disturbance of consciousness. On 04Jun2021 at 10:30 (the day of vaccination), the patient received?the first single dose of BNT162b2 (COMIRNATY, Solution for injection, Lot number EY2173; Expiration Date: 31Aug2021) intramuscular in the left arm for COVID-19 immunization (at the age of 93 years old). On 07Jun2021 at 11:45 (3 days after the vaccination) (as reported, pending clarification), the patient suddenly experienced respiratory arrest for about 5 minutes. Throat congestion with some sputum was removed. On 09Jun2021 (5 days after the vaccination), the patient experienced cardio-respiratory arrest / cardiac arrest which resulted in death without treatment. The patient died on 09Jun2021. An autopsy was not performed. Death cause was reported as cardiac arrest. The outcome of respiratory arrest was unknown. Clinical course was reported as follows: The patient received long-term treatment with stable condition. The reporter commented as follows: Her death was considered to be closely related to senility or her underlying diseases, but causality was unknown. The patient was a 93-year and 6-month-old female. Body temperature before vaccination was 37.1 degrees Centigrade. The patient had no specific family history. Additional medical history included late effects of cerebral infarction. Time of vaccination was amended from at 10:30 to 11:40 on 04Jun2021. The causality between the event and BNT162b2 as unassessable. Other possible cause(s) of the event such as any other diseases were reported as below: Advanced age and atrial fibrillation as underlying disease, but she had no tachycardia. Possibilities of senility, newly developed brainstem infarction, or myocardial infarction could not be ruled out. On 07Jun2021 at 11:40 (3 days after the vaccination) (as reported, pending clarification), the patient suddenly experienced cardiac arrest while bathing. Tachycardia was also noted. On 09Jun2021 (5 days after the vaccination), the patient suddenly experienced cardiac arrest and then died. Due to her advanced age, the patient was decided to not receive not receive resuscitation at the time of sudden change. The reporter commented as follows: Possibility of direct involvement of vaccination to her death was considered as low because of her advance age, various underlying diseases, and no symptoms within 2 days of vaccination. Autopsy was not conducted upon request. However, during her hospitalization, the patient had been stable condition; therefore, this case was reported.; Reported Cause(s) of Death: Cardiac arrest


VAERS ID: 1428845 (history)  
Form: Version 2.0  
Age: 86.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-06-07
Onset:2021-06-09
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-06-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EY5420 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Altered state of consciousness, Body temperature, Brain stem haemorrhage, Computerised tomogram head
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Haemorrhagic central nervous system vascular conditions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-06-09
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 202106; Test Name: Body temperature; Result Unstructured Data: Test Result:36.3 Centigrade; Test Date: 20210609; Test Name: head CT; Result Unstructured Data: Test Result:Cerebral haemorrhage (Brain stem haemorrhage); Comments: Brain stem haemorrhage
CDC Split Type: JPPFIZER INC2021680695

Write-up: Brain stem haemorrhage; Consciousness disturbed; This is a spontaneous report from a contactable physician received from the Regulatory Authority (RA). Regulatory authority report number is v21112791. The patient was an 86-year and 11-month-old female. Body temperature before vaccination was 36.3 degrees Centigrade (Jun2021). There were no points to be considered on the vaccine screening questionnaire (primary diseases, allergies, vaccinations and illnesses within the last one month, medications the patient was taking, past adverse effect history, growth status). On 07Jun2021 at 14:00 (the day of vaccination), the patient received the first dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number EY5420, Expiration date 31Aug2021) via an unspecified route of administration as a single dose for COVID-19 immunization. On 09Jun2021 at around 7:00(1 days 17 hours after the vaccination), the patient experienced Consciousness disturbed. The course of the event was as follows: On 08Jun2021 at 21:00, there was no particular change during bedtime. On 09Jun2021 at 7:00, the patient experienced consciousness disturbed when making rounds. The ambulance was transferred to the reporting physician''s hospital. The patient had a test of Head CT and Brain stem haemorrhage was diagnosed. The seriousness and the causality between the event and BNT162B2 were not provided. Event, brain stem haemorrhage was reported. Onset date of the event was 09Jun2021, around 7:00. The reporter classified the event, brain stem haemorrhage as serious (death).; Reported Cause(s) of Death: Brain stem haemorrhage; Consciousness disturbed


Result pages: prev   1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1280&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166